Mankind Pharma, a leading Indian pharmaceutical company, has launched a digital smart classroom initiative in Ghaziabad as part of its corporate social responsibility (CSR) program, KindCare. The initiative aims to provide quality education to underprivileged students and bridge the digital divide in the region. The company has set up modern classrooms equipped with digital tools, such as smartboards, computers, and internet connectivity, to create an engaging and interactive learning experience.<\/p>\n
The digital smart classrooms are designed to cater to the educational needs of students from marginalized communities, who often lack access to quality educational resources. The initiative is expected to benefit over 1,000 students in the first phase, with plans to expand to more schools and locations in the future. Mankind Pharma has partnered with local schools and NGOs to identify the most deserving students and provide them with access to these digital classrooms.<\/p>\n
The KindCare program is a comprehensive CSR initiative launched by Mankind Pharma to address various social and environmental issues, including education, healthcare, and environmental sustainability. The program focuses on creating a positive impact on the community and promoting inclusive growth. Through the digital smart classroom initiative, Mankind Pharma aims to not only improve the quality of education but also prepare students for the digital age.<\/p>\n
The company believes that education is a key driver of social mobility and economic growth, and that every child deserves access to quality education, regardless of their socio-economic background. By providing digital smart classrooms, Mankind Pharma is empowering students with the skills and knowledge required to succeed in an increasingly digital world. The initiative is also expected to have a positive impact on the local community, as it will help to create a more educated and skilled workforce, contributing to the region’s economic growth and development.<\/p>\n
Mankind Pharma’s commitment to CSR is reflected in its efforts to make a positive impact on the community. The company’s digital smart classroom initiative is a testament to its dedication to creating a better future for underprivileged students and promoting inclusive growth. By leveraging technology and partnerships, Mankind Pharma is bridging the digital divide and empowering students to achieve their full potential. The initiative is a step towards creating a more equitable and sustainable future, where every child has access to quality education and opportunities to succeed.<\/p>\n","protected":false},"excerpt":{"rendered":"
Mankind Pharma, a leading Indian pharmaceutical company, has launched a digital smart classroom initiative in Ghaziabad as part of its corporate social responsibility (CSR) program, KindCare. The initiative aims to provide quality education to underprivileged students and bridge the digital divide in the region. The company has set up modern classrooms equipped with digital tools, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[18,2],"tags":[],"class_list":["post-89823","post","type-post","status-publish","format-standard","hentry","category-mankind","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89820,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/18\/mankind-pharma-launches-cutting-edge-digital-classrooms-bolstering-community-centric-education-through-kindcare-initiative-as-reported-by-india-education-diary\/","url_meta":{"origin":89823,"position":0},"title":"Mankind Pharma launches cutting-edge digital classrooms, bolstering community-centric education through KindCare initiative, as reported by India Education Diary.","author":"Team Small News","date":"January 18, 2026","format":false,"excerpt":"Mankind Pharma, a leading pharmaceutical company, has launched digital smart classrooms as part of its KindCare initiative, aiming to revolutionize community-first education in India. The inauguration of these state-of-the-art classrooms marks a significant milestone in the company's efforts to bridge the educational gap and provide quality learning opportunities to underprivileged\u2026","rel":"","context":"In "Mankind"","block_context":{"text":"Mankind","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/mankind\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89792,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/13\/piramal-pharma-enhances-its-global-sustainability-rating-in-recent-corporate-assessment\/","url_meta":{"origin":89823,"position":1},"title":"Piramal Pharma Enhances Its Global Sustainability Rating in Recent Corporate Assessment.","author":"Team Small News","date":"January 13, 2026","format":false,"excerpt":"Piramal Pharma, a leading global pharmaceutical company, has achieved a significant improvement in its score on the Global Corporate Sustainability Assessment (CSA) conducted by S&P Global. The CSA is a widely recognized benchmark for assessing a company's sustainability performance, evaluating factors such as environmental, social, and governance (ESG) practices. In\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89907,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/02\/06\/piramal-critical-care-collaborates-with-blue-zone-to-launch-innovative-waste-anaesthetic-gas-recycling-initiative\/","url_meta":{"origin":89823,"position":2},"title":"Piramal Critical Care collaborates with Blue-Zone to launch innovative waste anaesthetic gas recycling initiative.","author":"Team Small News","date":"February 6, 2026","format":false,"excerpt":"Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This innovative collaboration seeks to address the significant problem of anaesthetic gas waste, which contributes\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89744,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/03\/indias-pharmaceutical-sector-faces-a-pivotal-year-of-transformation-adapting-to-change-and-embracing-a-shifting-worldwide-landscape-hindustan-times\/","url_meta":{"origin":89823,"position":3},"title":"India’s pharmaceutical sector faces a pivotal year of transformation: Adapting to change and embracing a shifting worldwide landscape | Hindustan Times","author":"Team Small News","date":"January 3, 2026","format":false,"excerpt":"The Indian pharmaceutical industry has faced significant challenges in recent years, but 2022 has been a defining year for the sector. The industry has had to navigate disruptions caused by the COVID-19 pandemic, regulatory changes, and global trade tensions. Despite these challenges, Indian pharma has shown resilience and adaptability, and\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89749,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/04\/aurobindo-pharma-pushes-back-deadline-to-purchase-26-stake-in-swarnaakshu-solar\/","url_meta":{"origin":89823,"position":4},"title":"Aurobindo Pharma Pushes Back Deadline to Purchase 26% Stake in Swarnaakshu Solar","author":"Team Small News","date":"January 4, 2026","format":false,"excerpt":"Aurobindo Pharma has extended the timeline to acquire a 26% stake in Swarnaakshu Solar, a solar power company. The acquisition is part of Aurobindo Pharma's strategy to diversify its business and invest in renewable energy. The company had initially planned to complete the acquisition by a certain deadline, but it\u2026","rel":"","context":"In "Aurobindo Pharma"","block_context":{"text":"Aurobindo Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/aurobindo-pharma\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89800,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/14\/apollo-hospitals-managing-director-denies-rumors-of-a-family-feud-citing-the-demerger-as-a-deliberate-business-strategy\/","url_meta":{"origin":89823,"position":5},"title":"Apollo Hospitals Managing Director denies rumors of a family feud, citing the demerger as a deliberate business strategy.","author":"Team Small News","date":"January 14, 2026","format":false,"excerpt":"Apollo Hospitals Enterprise is undergoing a significant restructuring process, spinning off its pharmacy and digital health businesses into a separate entity called Apollo HealthCo. Managing Director Suneeta Reddy has clarified that this decision is driven by a desire to enhance shareholder value and is not related to family differences or\u2026","rel":"","context":"In "Apollo Hospital"","block_context":{"text":"Apollo Hospital","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/apollo-hospital\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89823"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89823\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}